0
13

In This Issue
  |  
The American Journal of Psychiatry

July 01, 2011, Vol. 168, No. 7
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

   Listen to the Podcast | All Podcasts
In This Issue
In This Issue
Editorials
When Is Polypharmacy an Advantage?
Carol A. Tamminga, M.D.
The Search for Improved Antidepressant Strategies: Is Bigger Better?
William Coryell, M.D.
Antipsychotic Polypharmacy: Are Two Ever Better Than One?
Donald C. Goff, M.D.; Lisa Dixon, M.D., M.P.H.
Adapting Treatment to Patient Problems
Charles P. O'Brien, M.D., Ph.D.
Commentary
Neuroscience, Clinical Evidence, and the Future of Psychiatric Classification in DSM-5
David J. Kupfer, M.D.; Darrel A. Regier, M.D., M.P.H.
Reviews and Overviews
A Systematic Review of Treatments for Refractory Depression in Older People
Claudia Cooper, Ph.D., M.R.C.Psych.; Cornelius Katona, M.D., F.R.C.Psych.; Kostas Lyketsos, M.D., M.H.S.; Dan Blazer, M.D., Ph.D.; Henry Brodaty, M.D., F.R.A.N.Z.C.P.; Peter Rabins, M.D., M.P.H.; Carlos Augusto de Mendonça Lima, M.D., D.Sci.; Gill Livingston, M.D., F.R.C.Psych.
Articles
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
A. John Rush, M.D.; Madhukar H. Trivedi, M.D.; Jonathan W. Stewart, M.D.; Andrew A. Nierenberg, M.D.; Maurizio Fava, M.D.; Benji T. Kurian, M.D.; Diane Warden, Ph.D.; David W. Morris, Ph.D.; James F. Luther, M.A.; Mustafa M. Husain, M.D.; Ian A. Cook, M.D.; Richard C. Shelton, M.D.; Ira M. Lesser, M.D.; Susan G. Kornstein, M.D.; Stephen R. Wisniewski, Ph.D.
Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
Susan M. Essock, Ph.D.; Nina R. Schooler, Ph.D.; T. Scott Stroup, M.D., M.P.H.; Joseph P. McEvoy, M.D.; Ingrid Rojas; Carlos Jackson, Ph.D.; Nancy H. Covell, Ph.D.;
CME   Gabapentin Combined With Naltrexone for the Treatment of Alcohol Dependence
Raymond F. Anton, M.D.; Hugh Myrick, M.D.; Tara M. Wright, M.D.; Patricia K. Latham, Ph.D.; Alicia M. Baros, Ph.D.; L. Randolph Waid, Ph.D.; Patrick K. Randall, Ph.D.
Disruption in the Balance Between Goal-Directed Behavior and Habit Learning in Obsessive-Compulsive Disorder
Claire M. Gillan, B.A.; Martina Papmeyer, M.A.; Sharon Morein-Zamir, Ph.D.; Barbara J. Sahakian, Ph.D.; Naomi A. Fineberg, M.A., M.R.C.Psych.; Trevor W. Robbins, Ph.D.; Sanne de Wit, Ph.D.
Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [11C]ABP688 PET and Postmortem Study
Alexandra Deschwanden, M.S.; Beata Karolewicz, Ph.D.; Anteneh M. Feyissa, M.D.; Valerie Treyer, Ph.D.; Simon M. Ametamey, Ph.D.; Anass Johayem, Ph.D.; Cyrill Burger, Ph.D.; Yves P. Auberson, Ph.D.; Judit Sovago, M.D., Ph.D.; Craig A. Stockmeier, Ph.D.; Alfred Buck, M.D.; Gregor Hasler, M.D.
CME   Association of Predeployment Gaze Bias for Emotion Stimuli With Later Symptoms of PTSD and Depression in Soldiers Deployed in Iraq
Christopher G. Beevers, Ph.D.; Han-Joo Lee, Ph.D.; Tony T. Wells, M.A.; Alissa J. Ellis, M.A.; Michael J. Telch, Ph.D.
CME   A Prospective 2-Year Study of Emergency Department Patients With Early-Phase Primary Psychosis or Substance-Induced Psychosis
Robert E. Drake, M.D., Ph.D.; Carol L.M. Caton, Ph.D.; Haiyi Xie, Ph.D.; Eustace Hsu, M.A.; Prakash Gorroochurn, Ph.D.; Sharon Samet, Ph.D., L.C.S.W.; Deborah S. Hasin, Ph.D.
Clinical Case Conference
Buprenorphine for Prescription Opioid Addiction in a Patient With Depression and Alcohol Dependence
Marc J. Fishman, M.D.; Li-Tzy Wu, Sc.D.; George E. Woody, M.D.
Letters to the Editor
Comment on the Association of Stigma With Violence
Jason Matejkowski, Ph.D.; Sara Cullen, M.S.W.; Phyllis Solomon, Ph.D.
Response to Matejkowski et al. Letter
E. Fuller Torrey, M.D.
Anti-NMDA Receptor Encephalitis Versus Pediatric Catatonia
Dirk Dhossche, M.D, Ph.D.; Max Fink, M.D.; Edward Shorter, Ph.D.; Lee E. Wachtel, M.D.
Response to Dhossche et al. Letter
Meredith R. Chapman, M.D.; Holly E. Vause, D.N.P., P.M.H.N.P.-B.C.
Monitoring Ketamine Treatment Response in a Depressed Patient via Peripheral Mammalian Target of Rapamycin Activation
Magdalena C. Denk, M.D.; Christiane Rewerts, M.T.L.A.; Florian Holsboer, M.D., Ph.D.; Angelika Erhardt-Lehmann, M.D.; Christoph W. Turck, Ph.D.
The Asclepius: The Ancient Standard of Physicians
John A. Fromson, M.D.
Book Forum
Downing Street Blues: A History of Depression and Other Mental Afflictions in British Prime Ministers
Gordon B. Parker, M.D., Ph.D.
Struck by Living: From Depression to Hope
Conrad M. Swartz, Ph.D., M.D.
GABA and Sleep: Molecular, Functional and Clinical Aspects
Martin Reite, M.D.
Psychotherapy for the Treatment of Substance Abuse
Roger D. Weiss, M.D.
Images in Psychiatry
Paul Cézanne, 1839–1906
Peter J. Buckley, M.D.
Correction
Correction
  |  
Copyright ©
American
Psychiatric
Association